Search Results 401-410 of 17051 for pharmacogenetics
Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer. This study hopes ...
A small subset of the women who get diagnosed have inherited an abnormal copy of a gene that runs in families and can greatly increase their risk of certain ...
Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin, work in ...
View patient resources recommended by the Immuno-Epigenetics Lab led by William A. Faubion Jr., M.D., at Mayo Clinic's campus in Minnesota.
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
The Biliary Epigenetics and Regenerative Medicine Laboratory of Robert C. Huebert, M.D., at Mayo Clinic provides training, education and career ...
The purpose of this study is to characterize the risk of scoliosis progression based on local three-dimensional vertebral and pelvic measurements present on ...
This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...
The purpose of this study is to compare the effectiveness of temozolomide to selumetinib for the treatment of patients who have melanoma of the eye that has ...
Mayo Clinic's Zebrafish Genetics Lab led by Xiaolei Xu, Ph.D., is discovering genes that help develop individualized medicine for idiopathic dilated ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.